Global Hemodialysis and Peritoneal Dialysis Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024
Global Hemodialysis and Peritoneal Dialysis Market is expected to grow from USD 67.2 billion in 2017 to USD 99.7 billion in 2024, at a moderate CAGR of 5.9% from 2018 to 2024.
The growth in the market is attributed to the increasing number of patients diagnosed with end-stage renal disease along with growing number of patients suffering from diabetes and high blood pressure. Moreover, shortage of kidney donors, favorable healthcare insurance policies, and technological advancements and novel product innovations across the globe are also propelling the market growth.
The years used for the assessment are as follows;
Historical year: 2014, 2015, and 2016
Base year: 2017
Forecast period: 2018 – 2024
The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;
Obtaining historical data of the market based on news, articles, publications, annual reports, white papers, surveys, and other secondary sources
Interacting with key opinion leaders of the market and developing data points based on interaction with them
Study of past trends in the market and their year on year Impact on the market size and share
Analyzing the collected data points
Bridging the data points to calculate the total hemodialysis and peritoneal dialysis market and its various segments
Anticipating potential risks
Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global hemodialysis and peritoneal dialysis market
Finalizing the overall size and share of the global hemodialysis and peritoneal dialysis market
To analyze market trends, opportunities, drivers, and restraints associated with the global hemodialysis and peritoneal dialysis market
To study market response with respect to the mergers and acquisitions in the industry
To profile key companies operating in the hemodialysis and peritoneal dialysis market and provide their competitive landscape
The research scope for hemodialysis and peritoneal dialysis market is as follows:
Short Daily Hemodialysis
Continuous Ambulatory Peritoneal Dialysis (CAPD)
Automated Peritoneal Dialysis (APD)
Center-Use Hemodialysis Machines
Home-Use Hemodialysis Machines
Water Treatment System
Central Water Disinfection Systems
Portable Water Disinfection Systems
Dialysis centers & hospital-based dialysis
Central & South America
Middle East and Africa (MEA)
The major growth driver in the hemodialysis and peritoneal dialysis market is the rising number of patient suffering from high blood pressure and diabetes. The significant prevalence of chronic kidney diseases and growing aging population are other factors contributing towards the continuous growth of hemodialysis and peritoneal dialysis market. Moreover, evolution of new dialysis methods (such as nocturnal dialysis and home hemodialysis) in developing countries such as India and China, among others presents a lucrative growth opportunity for the market players in coming years.
The role of healthy kidney in the human body is to clean blood and remove extra fluids in the form of urine. The requirement for dialysis arises when the kidney is not able to filter extra waste fluids from the body. The dialysis treatment consists of two types of procedures; hemodialysis and peritoneal dialysis.
Geographically, North America held the largest share of the market in 2017. The growth in the region is mainly attributed to the high prevalence of diabetes and hypertension patients coupled with the adoption of new technologies. Moreover, growing number of dialysis centers and increasing awareness regarding the availability of various treatment options are further boosting the market growth in the region. Europe held the second largest share of the market in 2017. The growth in the region is attributed to the higher incidence of chronic kidney diseases, new product innovations, and growing number of patients suffering from diabetes and hypertension. Moreover, rising prevalence of end-stage renal diseases and growing aging population is further propelling the market growth in the region. Asia-Pacific held the third largest share of the market and is expected to witness the highest CAGR during the forecast period due to increasing awareness regarding kidney diseases, shortage of kidney donors and growing investments in research and development activities in the region.
Some of the key companies operating in the market include Fresenius Medical Care AG & Co. KGaA, Integer Holdings Corporation, Nxstage Medical, Inc., Allmed Medical Care Holdings Limited, Davita Healthcare Partners Inc., Asahi Kasei Medical Co., Ltd., Nipro Corporation, Diaverum Deutschland GmbH, Baxter International Inc., B. Braun Melsungen AG, and Nikkiso Co., Ltd., among others.